TRANSCEPT PHARMACEUTICALS Aktie

5,58 EUR -1,6564%

Zu Ihrem Onlinebroker

kaufen verkaufen

TRANSCEPT PHARMACEUTICALS Aktienkurs : 08:08 ( 15 Min. verzögert)
5,58 € Letzter Kurs	-1,66% Veränderung	5,68 € Vortag	5,58 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
5,58 - 5,58 Tag	8,61 - 1,76 52 Wochen	0 Tag	0 Ø 52 Wochen	5,61 800 Stücke	5,81 800 Stücke

TRANSCEPT PHARMACEUTICALS Akt…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

25.05.

Nasdaq stocks posting largest percentage increases

Transcept Pharmaceuticals Inc. rose 13.6 percent to $7.25. Taylor Devices Inc. rose 11.9 percent to $9.76. National Security Group rose 11.7 percent to $9.28. Osiris Therapeutics Inc. rose 11.5 perce…
16.05.

Intermezzo: A Nightmare Drug for Insomniacs?

The drug is made by Transcept Pharmaceuticals and is being marketed by Purdue Pharma (the maker of OxyContin) as their latest blockbuster drug. Purdue Pharma is spending...

16.05.

Transcept Pharmaceuticals Inc. Stock Downgraded (TSPT)

By TheStreet Wire 05/16/12 - 05:01 AM EDT NEW YORK (TheStreet) -- Transcept Pharmaceuticals (Nasdaq:TSPT) has been downgraded by TheStreet Ratings from hold to sell. The company's weaknesses can be seen in multiple areas,...
14.05.

Transcept Pharmaceuticals Reports First Quarter 2012 Financial Results

POINT RICHMOND, Calif., May 14, 2012 /PRNewswire via COMTEX/ -- Transcept Pharmaceuticals, Inc. (NASDAQ:TSPT) , a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important ...
14.05.

Transcept Pharmaceuticals Reports First Quarter 2012 Financial Results

POINT RICHMOND, Calif., May 14, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic...